IRIS
CAMPAGNA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.420
EU - Europa 447
AS - Asia 313
AF - Africa 1
SA - Sud America 1
Totale 2.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.416
CN - Cina 214
SE - Svezia 142
DE - Germania 87
SG - Singapore 59
UA - Ucraina 51
GB - Regno Unito 40
IT - Italia 36
VN - Vietnam 30
FI - Finlandia 27
RU - Federazione Russa 24
BE - Belgio 18
FR - Francia 11
IN - India 5
CA - Canada 3
IE - Irlanda 3
CH - Svizzera 2
HK - Hong Kong 2
IR - Iran 2
NL - Olanda 2
CL - Cile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
PK - Pakistan 1
PL - Polonia 1
Totale 2.182
Salva come PNG Salva come JPEG
Città #
Chandler 172
Fairfield 162
Jacksonville 117
Nyköping 106
Woodbridge 95
Houston 86
Ann Arbor 80
Ashburn 77
Wilmington 67
Cambridge 63
Dearborn 63
Seattle 63
Nanjing 49
Singapore 47
Dong Ket 28
Boardman 27
Lawrence 25
Roxbury 25
Bari 23
Munich 23
Brooklyn 22
Beijing 19
Brussels 18
Des Moines 18
Princeton 18
New York 17
Shenyang 13
Nanchang 11
Santa Clara 11
Jiaxing 8
Zhengzhou 8
Guangzhou 7
Hebei 7
Hefei 7
Kunming 7
Ningbo 7
Shanghai 7
Jinan 6
Los Angeles 6
Paris 6
San Diego 5
Changsha 4
Helsinki 4
Tianjin 4
West Jordan 4
Dublin 3
Inglewood 3
Jaipur 3
Marseille 3
Amsterdam 2
Grafing 2
Hanoi 2
Kansas City 2
St Albans 2
Taizhou 2
Toronto 2
Wuhan 2
Acton 1
Ardabil 1
Augusta 1
Boydton 1
Brno 1
Budapest 1
Buffalo 1
Cedar Knolls 1
Cerro Maggiore 1
Chengdu 1
Chiswick 1
Clifton 1
Düsseldorf 1
Foshan 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Heze 1
Hounslow 1
Huzhou 1
Indiana 1
Islington 1
Kilburn 1
Lagos 1
Leawood 1
Lishui 1
Malden 1
Modugno 1
Mumbai 1
Nagold 1
Nuremberg 1
Ottawa 1
Qingdao 1
Redmond 1
Redwood City 1
Rome 1
Romola 1
San Francisco 1
St Petersburg 1
Strasbourg 1
Taiyuan 1
Warsaw 1
Washington 1
Totale 1.713
Salva come PNG Salva come JPEG
Nome #
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships 220
Design, synthesis and biological evaluation of indane 2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as b-amyloid aggregation inhibitors 144
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Aβ40 aggregation in vitro 130
Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity 125
Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl) hydrazone: a water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity 113
Synthesis and antibacterial activity of pyridazino[4,3-b]indole-4-carboxylic acids carrying different substituents at N-2 102
Synthesis and antibacterial activity of 2-aryl-2,5-dihydro-3(3H)-oxo-pyridazino4,3-bindole-4-carboxylic acids 101
Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity 98
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 93
Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases 88
Synthesis and structure-affinity relationships at the central benzodiazepine receptor of pyridazino4,3-bindoles and indeno1,2-cpyridazines 81
Indol-3-ylidene, pyridazino[4,3-b]indole and indeno[1,2-c]pyrazole derivatives:synthesis and biological evaluation as inhibitors of GSK-3 and CDKs 73
Inhibiting Aβ1-40 in vitro aggregation by glycine-based molecular tongs: rational design and mechanistic implications 73
Biophysical Characterization of Inhibition of A-beta Fibril Formation by Isatin-3-arylhydrazones 70
New N-arylmethyl derivatives of some cyclic amino acids and new peptidomimetics: synthesis and inhibition activity of insulin amyloid formation 69
4-(ALKYL)AMINOMETHYL-SUBSTITUTED COUMARINS AS POTENT AND SELECTIVE ACHE AND MAO-B DUAL INHIBITORS WITH A THERAPEUTIC POTENTIAL IN NEURODEGENERATIVE DISORDERS 69
Synthesis and biological evaluation of pyrazoles and pyrazole-containing polycyclic derivatives as new ligands of central and peripheral benzodiazepine receptors 69
Synthesis and biological evaluation of arylhydrazone derivatives of indoles and indolin-2-ones as b-amyloid aggregation inhibitors 69
Benzodiazepine receptor affinities, behavioural and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol-3(3H)-ones in mice 68
Synthesis and biophysical evaluation of arylhydrazono-1H-2-indolinones as beta-amyloid aggregation inhibitors 64
Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterases 63
NOVEL GLUCOSE-CONJUGATED HIGHLY POTENT DUAL THROMBIN AND FACTOR Xa INHIBITORS AS POTENTIAL ANTITHROMBOTICS 62
Synthesis and Inhibitory Activity Towards β-Amyloid Fibril Formation of Indane and Indole Derivatives 60
The exploration of 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole derivatives as selective butyrylcholinesterase inhibitors 52
Synthesis and Monoamine Oxidase Inhibitory Activity of new Pyridazine-, Pyrimidine and 1,2,4 Triazine containing Tryciclic derivatives 43
Synthesis and biological evaluation of arylhydrazone derivatives of indoles and indolin-2-ones as b-amyloid aggregation inhibitors 10
Totale 2.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020328 0 0 0 0 0 77 82 53 56 18 36 6
2020/2021330 25 17 20 17 29 18 66 13 26 36 19 44
2021/2022222 10 27 2 10 7 10 11 10 11 36 43 45
2022/2023482 67 58 31 51 60 59 5 56 66 5 14 10
2023/2024130 13 17 5 25 4 21 5 3 2 8 6 21
2024/2025163 30 27 43 32 8 23 0 0 0 0 0 0
Totale 2.209